HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
The Hass Avocado Board in Mission Viejo formed a four-year partnership with the American Heart Association “to galvanize Americans to eat the recommended amounts of fruits and vegetables every day.”
Frost Data Capital in San Juan Capistrano will work with DST Systems Inc. in Kansas City, Mo., on big data analysis for healthcare companies.
Ensign Group Inc. in Mission Viejo plans to sell 16 urgent care facilities that are open or in development in the Seattle market to MultiCare Health System in Tacoma, Wash.
Allergan Plc’s local operations provide 1,563 jobs here with a combined payroll of about $307 million, based on the company’s average salary statewide, an economic impact study said.
Carrick Capital Partners in Newport Beach has invested $50 million in InstaMed in Philadelphia.
OCTANe in Aliso Viejo will merge with Orange County Technology Alliance in Mission Viejo.
Johnson & Johnson in New Brunswick, N.J. will buy Abbott Medical Optics in Santa Ana for $4.3 billion in cash. The deal is expected to close early next year.
Aerie Pharmaceuticals Inc. plans to offer $125 million in stock next week.
Chapman University’s School of Pharmacy has opened its first center, which focuses on targeted drug delivery.
Allergan Plc will buy Vitae Pharmaceuticals Inc. for about $639 million.
The La Palma-based Innovation Institute has signed an agreement with the Westport, Conn.-based Society of Physician Entrepreneurs, a biomedical and healthcare innovation network of more than 25,000 members in some 20 chapters worldwide.
AcuFocus Inc. in Irvine received $66 million in a funding round led by KKR & Co. LLP in New York.
Rox Medical in San Clemente got $40 million in Series E financing led by Novartis Venture Fund and Apple Tree Partners, with participation by Versant Ventures and Domain Associates.
Blockade Medical in Irvine has been sold to Balt International in Paris on undisclosed terms.
Allergan Plc bought RetroSense Therapeutics for $60 million and milestone payments.